{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:46:09Z","timestamp":1794944769479,"version":"4.9.1"},"reference-count":241,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1038\/s41582-023-00884-1","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T16:02:09Z","timestamp":1699891329000},"page":"737-753","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":171,"title":["Molecular biomarkers for vascular cognitive impairment and dementia"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4241-3677","authenticated-orcid":false,"given":"Satoshi","family":"Hosoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2221-9428","authenticated-orcid":false,"given":"Gurpreet K.","family":"Hansra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharusha","family":"Jayasena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9953-1984","authenticated-orcid":false,"given":"Anne","family":"Poljak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Mather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9892-0547","authenticated-orcid":false,"given":"Vibeke S.","family":"Catts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3376-3453","authenticated-orcid":false,"given":"Ruslan","family":"Rust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8178-3785","authenticated-orcid":false,"given":"Abhay","family":"Sagare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Kovacic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Brodtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9506-0513","authenticated-orcid":false,"given":"Anders","family":"Wallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6802-8232","authenticated-orcid":false,"given":"Berislav V.","family":"Zlokovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7102-4048","authenticated-orcid":false,"given":"Masafumi","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9595-3220","authenticated-orcid":false,"given":"Perminder S.","family":"Sachdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"884_CR1","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick, P. B. et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 42, 2672\u20132713 (2011). An overall guide for practitioners to gain a better understanding of VCID.","journal-title":"Stroke"},{"key":"884_CR2","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1097\/00002093-199912003-00017","volume":"13","author":"RN Kalaria","year":"1999","unstructured":"Kalaria, R. N. & Ballard, C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis. Assoc. Disord. 13, S115\u2013S123 (1999).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"884_CR3","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/j.jacc.2019.04.034","volume":"73","author":"C Iadecola","year":"2019","unstructured":"Iadecola, C. et al. Vascular cognitive impairment and dementia: JACC Scientific Expert Panel. J. Am. Coll. Cardiol. 73, 3326\u20133344 (2019). A critical appraisal of the epidemiology, pathobiology, neuropathology and neuroimaging of VCID.","journal-title":"J. Am. Coll. Cardiol."},{"key":"884_CR4","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/alz.12283","volume":"17","author":"J Simr\u00e9n","year":"2021","unstructured":"Simr\u00e9n, J. et al. The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer\u2019s disease. Alzheimers Dement. 17, 1145\u20131156 (2021).","journal-title":"Alzheimers Dement."},{"key":"884_CR5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr.","year":"2018","unstructured":"Jack, C. R. Jr. et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement."},{"key":"884_CR6","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","volume":"80","author":"C Iadecola","year":"2013","unstructured":"Iadecola, C. The pathobiology of vascular dementia. Neuron 80, 844\u2013866 (2013). A review of the pathophysiology of VCID.","journal-title":"Neuron"},{"key":"884_CR7","doi-asserted-by":"crossref","first-page":"18003","DOI":"10.1038\/nrdp.2018.3","volume":"4","author":"WM van der Flier","year":"2018","unstructured":"van der Flier, W. M. et al. Vascular cognitive impairment. Nat. Rev. Dis. Prim. 4, 18003 (2018). A comprehensive review of VCID.","journal-title":"Nat. Rev. Dis. Prim."},{"key":"884_CR8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1124\/jpet.300.3.762","volume":"300","author":"XJ Zhou","year":"2002","unstructured":"Zhou, X. J., Vaziri, N. D., Wang, X. Q., Silva, F. G. & Laszik, Z. Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase. J. Pharmacol. Exp. Ther. 300, 762\u2013767 (2002).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"884_CR9","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.3390\/jcm9093026","volume":"9","author":"L Dowsett","year":"2020","unstructured":"Dowsett, L. et al. ADMA: a key player in the relationship between vascular dysfunction and inflammation in atherosclerosis. J. Clin. Med. 9, 3026 (2020).","journal-title":"J. Clin. Med."},{"key":"884_CR10","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/CIRCRESAHA.118.313260","volume":"124","author":"C Iadecola","year":"2019","unstructured":"Iadecola, C. & Gottesman, R. F. Neurovascular and cognitive dysfunction in hypertension. Circ. Res. 124, 1025\u20131044 (2019).","journal-title":"Circ. Res."},{"key":"884_CR11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","volume":"96","author":"C Iadecola","year":"2017","unstructured":"Iadecola, C. The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron 96, 17\u201342 (2017).","journal-title":"Neuron"},{"key":"884_CR12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ana.22553","volume":"71","author":"DN Kernagis","year":"2012","unstructured":"Kernagis, D. N. & Laskowitz, D. T. Evolving role of biomarkers in acute cerebrovascular disease. Ann. Neurol. 71, 289\u2013303 (2012).","journal-title":"Ann. Neurol."},{"key":"884_CR13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41593-017-0059-z","volume":"21","author":"G Faraco","year":"2018","unstructured":"Faraco, G. et al. Dietary salt promotes neurovascular and cognitive dysfunction through a gut-initiated TH17 response. Nat. Neurosci. 21, 240\u2013249 (2018).","journal-title":"Nat. Neurosci."},{"key":"884_CR14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41586-019-1688-z","volume":"574","author":"G Faraco","year":"2019","unstructured":"Faraco, G. et al. Dietary salt promotes cognitive impairment through tau phosphorylation. Nature 574, 686\u2013690 (2019).","journal-title":"Nature"},{"key":"884_CR15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/bcpt.13377","volume":"127","author":"H Shimokawa","year":"2020","unstructured":"Shimokawa, H. & Godo, S. Nitric oxide and endothelium-dependent hyperpolarization mediated by hydrogen peroxide in health and disease. Basic Clin. Pharmacol. Toxicol. 127, 92\u2013101 (2020).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"884_CR16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic, B. V. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat. Rev. Neurosci. 12, 723\u2013738 (2011). A review of pathophysiology of the neurovascular unit.","journal-title":"Nat. Rev. Neurosci."},{"key":"884_CR17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney, M. D., Sagare, A. P. & Zlokovic, B. V. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 14, 133\u2013150 (2018). A review of the blood\u2013brain barrier in Alzheimer disease and other neurodegenerative disorders.","journal-title":"Nat. Rev. Neurol."},{"key":"884_CR18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation, D. A. et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat. Med. 25, 270\u2013276 (2019).","journal-title":"Nat. Med."},{"key":"884_CR19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/alz.12061","volume":"16","author":"MD Sweeney","year":"2020","unstructured":"Sweeney, M. D. et al. A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid. Alzheimers Dement. 16, 821\u2013830 (2020).","journal-title":"Alzheimers Dement."},{"key":"884_CR20","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1161\/STROKEAHA.122.039211","volume":"53","author":"GA Rosenberg","year":"2022","unstructured":"Rosenberg, G. A. Willis lecture: biomarkers for inflammatory white matter injury in Binswanger disease provide pathways to precision medicine. Stroke 53, 3514\u20133523 (2022).","journal-title":"Stroke"},{"key":"884_CR21","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41593-019-0434-z","volume":"22","author":"AM Nikolakopoulou","year":"2019","unstructured":"Nikolakopoulou, A. M. et al. Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss. Nat. Neurosci. 22, 1089\u20131098 (2019).","journal-title":"Nat. Neurosci."},{"key":"884_CR22","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.ajpath.2021.07.003","volume":"191","author":"TV Procter","year":"2021","unstructured":"Procter, T. V., Williams, A. & Montagne, A. Interplay between brain pericytes and endothelial cells in dementia. Am. J. Pathol. 191, 1917\u20131931 (2021).","journal-title":"Am. J. Pathol."},{"key":"884_CR23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik, A. et al. Pericytes regulate the blood-brain barrier. Nature 468, 557\u2013561 (2010).","journal-title":"Nature"},{"key":"884_CR24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C. & Gage, F. H. Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918\u2013934 (2010).","journal-title":"Cell"},{"key":"884_CR25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/hr.2010.201","volume":"34","author":"RM Touyz","year":"2011","unstructured":"Touyz, R. M. & Briones, A. M. Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens. Res. 34, 5\u201314 (2011).","journal-title":"Hypertens. Res."},{"key":"884_CR26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/10739680701641421","volume":"15","author":"WG Mayhan","year":"2008","unstructured":"Mayhan, W. G., Arrick, D. M., Sharpe, G. M. & Sun, H. Age-related alterations in reactivity of cerebral arterioles: role of oxidative stress. Microcirculation 15, 225\u2013236 (2008).","journal-title":"Microcirculation"},{"key":"884_CR27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/HYPERTENSIONAHA.111.173534","volume":"58","author":"YF Dong","year":"2011","unstructured":"Dong, Y. F. et al. Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion. Hypertension 58, 635\u2013642 (2011).","journal-title":"Hypertension"},{"key":"884_CR28","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/jnc.12824","volume":"131","author":"AV Santhanam","year":"2014","unstructured":"Santhanam, A. V., d\u2019Uscio, L. V. & Katusic, Z. S. Erythropoietin increases bioavailability of tetrahydrobiopterin and protects cerebral microvasculature against oxidative stress induced by eNOS uncoupling. J. Neurochem. 131, 521\u2013529 (2014).","journal-title":"J. Neurochem."},{"key":"884_CR29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11010-019-03553-4","volume":"459","author":"K Prasad","year":"2019","unstructured":"Prasad, K. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer\u2019s disease. Mol. Cell Biochem. 459, 95\u2013112 (2019).","journal-title":"Mol. Cell Biochem."},{"key":"884_CR30","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","volume":"53","author":"Y Tang","year":"2016","unstructured":"Tang, Y. & Le, W. Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol. Neurobiol. 53, 1181\u20131194 (2016).","journal-title":"Mol. Neurobiol."},{"key":"884_CR31","doi-asserted-by":"crossref","first-page":"815347","DOI":"10.3389\/fnagi.2022.815347","volume":"14","author":"S Guo","year":"2022","unstructured":"Guo, S., Wang, H. & Yin, Y. Microglia polarization from M1 to M2 in neurodegenerative diseases. Front. Aging Neurosci. 14, 815347 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"884_CR32","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.3390\/ijms21186676","volume":"21","author":"E Kim","year":"2020","unstructured":"Kim, E., Otgontenger, U., Jamsranjav, A. & Kim, S. S. Deleterious alteration of glia in the brain of Alzheimer\u2019s disease. Int. J. Mol. Sci. 21, 6676 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"884_CR33","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1161\/STROKEAHA.110.584920","volume":"41","author":"B Chen","year":"2010","unstructured":"Chen, B., Cheng, Q., Yang, K. & Lyden, P. D. Thrombin mediates severe neurovascular injury during ischemia. Stroke 41, 2348\u20132352 (2010).","journal-title":"Stroke"},{"key":"884_CR34","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.3390\/ani12192487","volume":"12","author":"A Zoia","year":"2022","unstructured":"Zoia, A., Drigo, M., Caldin, M., Simioni, P. & Piek, C. J. Fibrinolysis in dogs with intracavitary effusion: a review. Animals 12, 2487 (2022).","journal-title":"Animals"},{"key":"884_CR35","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0092-8674(00)80483-3","volume":"91","author":"ZL Chen","year":"1997","unstructured":"Chen, Z. L. & Strickland, S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91, 917\u2013925 (1997).","journal-title":"Cell"},{"key":"884_CR36","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00004647-200107000-00008","volume":"21","author":"M Ihara","year":"2001","unstructured":"Ihara, M. et al. Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter. J. Cereb. Blood Flow Metab. 21, 828\u2013834 (2001).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"884_CR37","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1523\/JNEUROSCI.0035-09.2009","volume":"29","author":"K Arai","year":"2009","unstructured":"Arai, K. & Lo, E. H. An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells. J. Neurosci. 29, 4351\u20134355 (2009).","journal-title":"J. Neurosci."},{"key":"884_CR38","doi-asserted-by":"crossref","first-page":"978761","DOI":"10.4061\/2011\/978761","volume":"2011","author":"M Ihara","year":"2011","unstructured":"Ihara, M. & Tomimoto, H. Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changes. J. Aging Res. 2011, 978761 (2011).","journal-title":"J. Aging Res."},{"key":"884_CR39","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jnc.14218","volume":"144","author":"GA Rosenberg","year":"2018","unstructured":"Rosenberg, G. A. Binswanger\u2019s disease: biomarkers in the inflammatory form of vascular cognitive impairment and dementia. J. Neurochem. 144, 634\u2013643 (2018).","journal-title":"J. Neurochem."},{"key":"884_CR40","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1212\/WNL.0000000000000312","volume":"82","author":"JM Wardlaw","year":"2014","unstructured":"Wardlaw, J. M. et al. Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities. Neurology 82, 1331\u20131338 (2014).","journal-title":"Neurology"},{"key":"884_CR41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCULATIONAHA.120.046657","volume":"143","author":"D Saadoun","year":"2021","unstructured":"Saadoun, D., Vautier, M. & Cacoub, P. Medium- and large-vessel vasculitis. Circulation 143, 267\u2013282 (2021).","journal-title":"Circulation"},{"key":"884_CR42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/HYPERTENSIONAHA.114.03617","volume":"65","author":"Z Sun","year":"2015","unstructured":"Sun, Z. Aging, arterial stiffness, and hypertension. Hypertension 65, 252\u2013256 (2015).","journal-title":"Hypertension"},{"key":"884_CR43","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/ATVBAHA.107.161521","volume":"29","author":"K Gaengel","year":"2009","unstructured":"Gaengel, K., Genov\u00e9, G., Armulik, A. & Betsholtz, C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 29, 630\u2013638 (2009).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"884_CR44","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1476-511X-10-170","volume":"10","author":"IT Silva","year":"2011","unstructured":"Silva, I. T., Mello, A. P. & Damasceno, N. R. Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A2 (Lp-PLA2): a review. Lipids Health Dis. 10, 170 (2011).","journal-title":"Lipids Health Dis."},{"key":"884_CR45","doi-asserted-by":"crossref","first-page":"673440","DOI":"10.3389\/fnins.2021.673440","volume":"15","author":"YT Huang","year":"2021","unstructured":"Huang, Y. T., Hong, F. F. & Yang, S. L. Atherosclerosis: the culprit and co-victim of vascular dementia. Front. Neurosci. 15, 673440 (2021).","journal-title":"Front. Neurosci."},{"key":"884_CR46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0021-9150(70)90029-8","volume":"11","author":"C Velican","year":"1970","unstructured":"Velican, C. Studies on the age-related changes occurring in human cerebral arteries. Atherosclerosis 11, 509\u2013529 (1970).","journal-title":"Atherosclerosis"},{"key":"884_CR47","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/CIRCULATIONAHA.114.011147","volume":"130","author":"K Ritz","year":"2014","unstructured":"Ritz, K., Denswil, N. P., Stam, O. C., van Lieshout, J. J. & Daemen, M. J. Cause and mechanisms of intracranial atherosclerosis. Circulation 130, 1407\u20131414 (2014). A review of the pathophysiology of intracranial atherosclerosis.","journal-title":"Circulation"},{"key":"884_CR48","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archneur.1964.00460180083008","volume":"10","author":"JA Resch","year":"1964","unstructured":"Resch, J. A. & Baker, A. B. Etiologic mechanisms in cerebral atherosclerosis. Preliminary study of 3,839 cases. Arch. Neurol. 10, 617\u2013628 (1964).","journal-title":"Arch. Neurol."},{"key":"884_CR49","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1161\/hs1101.098520","volume":"32","author":"FP D\u2019Armiento","year":"2001","unstructured":"D\u2019Armiento, F. P. et al. Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke 32, 2472\u20132479 (2001).","journal-title":"Stroke"},{"key":"884_CR50","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0735-1097(94)90644-0","volume":"23","author":"D Fatkin","year":"1994","unstructured":"Fatkin, D., Kelly, R. P. & Feneley, M. P. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J. Am. Coll. Cardiol. 23, 961\u2013969 (1994).","journal-title":"J. Am. Coll. Cardiol."},{"key":"884_CR51","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ehj.2003.08.021","volume":"24","author":"AD Blann","year":"2003","unstructured":"Blann, A. D., Nadar, S. K. & Lip, G. Y. The adhesion molecule P-selectin and cardiovascular disease. Eur. Heart J. 24, 2166\u20132179 (2003).","journal-title":"Eur. Heart J."},{"key":"884_CR52","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1161\/STROKEAHA.115.012004","volume":"47","author":"H Kamel","year":"2016","unstructured":"Kamel, H., Okin, P. M., Elkind, M. S. & Iadecola, C. Atrial fibrillation and mechanisms of stroke: time for a new model. Stroke 47, 895\u2013900 (2016).","journal-title":"Stroke"},{"key":"884_CR53","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.121.319949","volume":"130","author":"J Magid-Bernstein","year":"2022","unstructured":"Magid-Bernstein, J. et al. Cerebral hemorrhage: pathophysiology, treatment, and future directions. Circ. Res. 130, 1204\u20131229 (2022). A review of the pathophysiology of cerebral haemorrhage.","journal-title":"Circ. Res."},{"key":"884_CR54","doi-asserted-by":"crossref","first-page":"e1807","DOI":"10.1212\/WNL.0000000000010418","volume":"95","author":"WMT Jolink","year":"2020","unstructured":"Jolink, W. M. T. et al. Location-specific risk factors for intracerebral hemorrhage: systematic review and meta-analysis. Neurology 95, e1807\u2013e1818 (2020).","journal-title":"Neurology"},{"key":"884_CR55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142338","volume":"10","author":"PH Kremer","year":"2015","unstructured":"Kremer, P. H., Jolink, W. M., Kappelle, L. J., Algra, A. & Klijn, C. J. Risk factors for lobar and non-lobar intracerebral hemorrhage in patients with vascular disease. PLoS ONE 10, e0142338 (2015).","journal-title":"PLoS ONE"},{"key":"884_CR56","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/s41379-021-00847-1","volume":"34","author":"S Magaki","year":"2021","unstructured":"Magaki, S. et al. Charcot-Bouchard aneurysms revisited: clinicopathologic correlations. Mod. Pathol. 34, 2109\u20132121 (2021).","journal-title":"Mod. Pathol."},{"key":"884_CR57","doi-asserted-by":"crossref","first-page":"1027756","DOI":"10.3389\/fimmu.2022.1027756","volume":"13","author":"J Jin","year":"2022","unstructured":"Jin, J. et al. Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): relevant signaling pathways and therapeutic strategies. Front. Immunol. 13, 1027756 (2022).","journal-title":"Front. Immunol."},{"key":"884_CR58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1517\/14728221003586836","volume":"14","author":"T Aoki","year":"2010","unstructured":"Aoki, T. & Nishimura, M. Targeting chronic inflammation in cerebral aneurysms: focusing on NF-kappaB as a putative target of medical therapy. Expert Opin. Ther. Targets 14, 265\u2013273 (2010).","journal-title":"Expert Opin. Ther. Targets"},{"key":"884_CR59","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tips.2012.02.004","volume":"33","author":"T Aoki","year":"2012","unstructured":"Aoki, T. & Narumiya, S. Prostaglandins and chronic inflammation. Trends Pharmacol. Sci. 33, 304\u2013311 (2012).","journal-title":"Trends Pharmacol. Sci."},{"key":"884_CR60","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2174\/1570159X19666211101103646","volume":"20","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. New mechanisms and targets of subarachnoid hemorrhage: a focus on mitochondria. Curr. Neuropharmacol. 20, 1278\u20131296 (2022).","journal-title":"Curr. Neuropharmacol."},{"key":"884_CR61","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/jnnp-2014-307711","volume":"85","author":"KP Budohoski","year":"2014","unstructured":"Budohoski, K. P. et al. The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry 85, 1343\u20131353 (2014). A review of the pathophysiology of subarachnoid haemorrhage.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"884_CR62","unstructured":"National Center for Advancing Translational Sciences (NCATS). Toolkit for patient-focused therapy development. https:\/\/toolkit.ncats.nih.gov\/module\/discovery\/developing-translational-research-tools\/biomarkers\/ (accessed 19 October 2023)."},{"key":"884_CR63","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1212\/WNL.0000000000001279","volume":"84","author":"A Shoamanesh","year":"2015","unstructured":"Shoamanesh, A. et al. Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study. Neurology 84, 825\u2013832 (2015).","journal-title":"Neurology"},{"key":"884_CR64","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jns.2008.05.020","volume":"272","author":"G Zuliani","year":"2008","unstructured":"Zuliani, G. et al. Markers of endothelial dysfunction in older subjects with late onset Alzheimer\u2019s disease or vascular dementia. J. Neurol. Sci. 272, 164\u2013170 (2008).","journal-title":"J. Neurol. Sci."},{"key":"884_CR65","doi-asserted-by":"crossref","first-page":"104646","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104646","volume":"29","author":"N El Husseini","year":"2020","unstructured":"El Husseini, N. et al. Vascular cellular adhesion molecule-1 (VCAM-1) and memory impairment in African-Americans after small vessel-type stroke. J. Stroke Cerebrovasc. Dis. 29, 104646 (2020).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"884_CR66","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","volume":"61","author":"MJ Engelhart","year":"2004","unstructured":"Engelhart, M. J. et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam Study. Arch. Neurol. 61, 668\u2013672 (2004).","journal-title":"Arch. Neurol."},{"key":"884_CR67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000353671","volume":"36","author":"PC Lavallee","year":"2013","unstructured":"Lavallee, P. C. et al. Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease. Cerebrovasc. Dis. 36, 131\u2013138 (2013).","journal-title":"Cerebrovasc. Dis."},{"key":"884_CR68","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50778-w","volume":"9","author":"F Janes","year":"2019","unstructured":"Janes, F. et al. ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. Sci. Rep. 9, 14207 (2019).","journal-title":"Sci. Rep."},{"key":"884_CR69","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1161\/STROKEAHA.109.557116","volume":"40","author":"A Pikula","year":"2009","unstructured":"Pikula, A. et al. Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham Offspring Study. Stroke 40, 2959\u20132964 (2009).","journal-title":"Stroke"},{"key":"884_CR70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2015.04.031","volume":"354","author":"Q Gao","year":"2015","unstructured":"Gao, Q. et al. S100B and ADMA in cerebral small vessel disease and cognitive dysfunction. J. Neurol. Sci. 354, 27\u201332 (2015).","journal-title":"J. Neurol. Sci."},{"key":"884_CR71","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ajh.2008.346","volume":"22","author":"Y Notsu","year":"2009","unstructured":"Notsu, Y. et al. Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage. Am. J. Hypertens. 22, 257\u2013262 (2009).","journal-title":"Am. J. Hypertens."},{"key":"884_CR72","first-page":"100007","volume":"2","author":"M Ihara","year":"2021","unstructured":"Ihara, M., Washida, K., Yoshimoto, T. & Saito, S. Adrenomedullin: a vasoactive agent for sporadic and hereditary vascular cognitive impairment. Cereb. Circ. Cogn. Behav. 2, 100007 (2021).","journal-title":"Cereb. Circ. Cogn. Behav."},{"key":"884_CR73","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2826.2002.00778.x","volume":"14","author":"B Kis","year":"2002","unstructured":"Kis, B. et al. Cerebral endothelial cells are a major source of adrenomedullin. J. Neuroendocrinol. 14, 283\u2013293 (2002).","journal-title":"J. Neuroendocrinol."},{"key":"884_CR74","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3233\/JAD-160901","volume":"56","author":"N Kuriyama","year":"2017","unstructured":"Kuriyama, N. et al. Association between mid-regional proadrenomedullin levels and progression of deep white matter lesions in the brain accompanying cognitive decline. J. Alzheimers Dis. 56, 1253\u20131262 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"884_CR75","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","volume":"7","author":"P Carmeliet","year":"2001","unstructured":"Carmeliet, P. et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7, 575\u2013583 (2001).","journal-title":"Nat. Med."},{"key":"884_CR76","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1002\/alz.12974","volume":"19","author":"JD Hinman","year":"2023","unstructured":"Hinman, J. D. et al. Placental growth factor as a sensitive biomarker for vascular cognitive impairment. Alzheimers Dement. 19, 3519\u20133527 (2023).","journal-title":"Alzheimers Dement."},{"key":"884_CR77","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/molehr\/gav069","volume":"22","author":"RL Luna","year":"2016","unstructured":"Luna, R. L. et al. Placental growth factor deficiency is associated with impaired cerebral vascular development in mice. Mol. Hum. Reprod. 22, 130\u2013142 (2016).","journal-title":"Mol. Hum. Reprod."},{"key":"884_CR78","doi-asserted-by":"crossref","first-page":"717344","DOI":"10.3389\/fnagi.2021.717344","volume":"13","author":"EB Erhardt","year":"2021","unstructured":"Erhardt, E. B. et al. Inflammatory biomarkers aid in diagnosis of dementia. Front. Aging Neurosci. 13, 717344 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"884_CR79","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-021-00512-w","volume":"17","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Dynamic changes of CSF sPDGFR\u03b2 during ageing and AD progression and associations with CSF ATN biomarkers. Mol. Neurodegener. 17, 9 (2022).","journal-title":"Mol. Neurodegener."},{"key":"884_CR80","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2015.09.025","volume":"607","author":"AP Sagare","year":"2015","unstructured":"Sagare, A. P., Sweeney, M. D., Makshanoff, J. & Zlokovic, B. V. Shedding of soluble platelet-derived growth factor receptor-\u03b2 from human brain pericytes. Neurosci. Lett. 607, 97\u2013101 (2015).","journal-title":"Neurosci. Lett."},{"key":"884_CR81","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne, A. et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85, 296\u2013302 (2015).","journal-title":"Neuron"},{"key":"884_CR82","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13195-019-0534-8","volume":"11","author":"JS Miners","year":"2019","unstructured":"Miners, J. S., Kehoe, P. G., Love, S., Zetterberg, H. & Blennow, K. CSF evidence of pericyte damage in Alzheimer\u2019s disease is associated with markers of blood-brain barrier dysfunction and disease pathology. Alzheimers Res. Ther. 11, 81 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"884_CR83","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13195-023-01199-5","volume":"15","author":"X Lv","year":"2023","unstructured":"Lv, X. et al. Changes in CSF sPDGFR\u03b2 level and their association with blood-brain barrier breakdown in Alzheimer\u2019s disease with or without small cerebrovascular lesions. Alzheimers Res. Ther. 15, 51 (2023).","journal-title":"Alzheimers Res. Ther."},{"key":"884_CR84","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3233\/JAD-2011-110566","volume":"27","author":"M Bjerke","year":"2011","unstructured":"Bjerke, M. et al. Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer\u2019s disease. J. Alzheimers Dis. 27, 665\u2013676 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"884_CR85","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1161\/01.STR.0000127420.10990.76","volume":"35","author":"JC Adair","year":"2004","unstructured":"Adair, J. C. et al. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke 35, e159\u2013e162 (2004).","journal-title":"Stroke"},{"key":"884_CR86","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/STROKEAHA.110.600825","volume":"42","author":"E Candelario-Jalil","year":"2011","unstructured":"Candelario-Jalil, E. et al. Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment. Stroke 42, 1345\u20131350 (2011).","journal-title":"Stroke"},{"key":"884_CR87","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1177\/0271678X18762655","volume":"39","author":"EB Erhardt","year":"2019","unstructured":"Erhardt, E. B. et al. Biomarkers identify the Binswanger type of vascular cognitive impairment. J. Cereb. Blood Flow Metab. 39, 1602\u20131612 (2019).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"884_CR88","doi-asserted-by":"crossref","first-page":"949129","DOI":"10.3389\/fnins.2022.949129","volume":"16","author":"M Gong","year":"2022","unstructured":"Gong, M. & Jia, J. Contribution of blood-brain barrier-related blood-borne factors for Alzheimer\u2019s disease vs. vascular dementia diagnosis: a pilot study. Front. Neurosci. 16, 949129 (2022).","journal-title":"Front. Neurosci."},{"key":"884_CR89","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-017-0877-3","volume":"17","author":"A Wallin","year":"2017","unstructured":"Wallin, A. et al. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease \u2014 a consensus report. BMC Neurol. 17, 102 (2017). A review of biomarkers associated with VCID.","journal-title":"BMC Neurol."},{"key":"884_CR90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.06.028","volume":"59","author":"T Skillback","year":"2017","unstructured":"Skillback, T. et al. CSF\/serum albumin ratio in dementias: a cross-sectional study on 1861 patients. Neurobiol. Aging 59, 1\u20139 (2017).","journal-title":"Neurobiol. Aging"},{"key":"884_CR91","volume":"14","author":"P Kettunen","year":"2022","unstructured":"Kettunen, P. et al. Blood-brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein-\u03b2 in patients with subcortical small-vessel disease. Alzheimers Dement. 14, e12296 (2022).","journal-title":"Alzheimers Dement."},{"key":"884_CR92","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10715760903440153","volume":"44","author":"L Li","year":"2010","unstructured":"Li, L. et al. Oxidative LDL modification is increased in vascular dementia and is inversely associated with cognitive performance. Free Radic. Res. 44, 241\u2013248 (2010).","journal-title":"Free Radic. Res."},{"key":"884_CR93","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.neurobiolaging.2014.02.007","volume":"35","author":"J Murr","year":"2014","unstructured":"Murr, J., Carmichael, P. H., Julien, P. & Laurin, D. Plasma oxidized low-density lipoprotein levels and risk of Alzheimer\u2019s disease. Neurobiol. Aging 35, 1833\u20131838 (2014).","journal-title":"Neurobiol. Aging"},{"key":"884_CR94","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.atherosclerosis.2014.04.032","volume":"235","author":"AL Fitzpatrick","year":"2014","unstructured":"Fitzpatrick, A. L. et al. Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study. Atherosclerosis 235, 384\u2013391 (2014).","journal-title":"Atherosclerosis"},{"key":"884_CR95","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1161\/STROKEAHA.109.559567","volume":"40","author":"CB Wright","year":"2009","unstructured":"Wright, C. B. et al. Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke 40, 3466\u20133471 (2009).","journal-title":"Stroke"},{"key":"884_CR96","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","volume":"11","author":"H Esterbauer","year":"1991","unstructured":"Esterbauer, H., Schaur, R. J. & Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81\u2013128 (1991).","journal-title":"Free Radic. Biol. Med."},{"key":"884_CR97","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1447-0594.2009.00571.x","volume":"10","author":"K Gustaw-Rothenberg","year":"2010","unstructured":"Gustaw-Rothenberg, K., Kowalczuk, K. & Stryjecka-Zimmer, M. Lipids\u2019 peroxidation markers in Alzheimer\u2019s disease and vascular dementia. Geriatr. Gerontol. Int. 10, 161\u2013166 (2010).","journal-title":"Geriatr. Gerontol. Int."},{"key":"884_CR98","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000080027","volume":"18","author":"MC Polidori","year":"2004","unstructured":"Polidori, M. C. et al. Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia. Dement. Geriatr. Cogn. Disord. 18, 265\u2013270 (2004).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"884_CR99","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000329568","volume":"9","author":"AA Helmy","year":"2012","unstructured":"Helmy, A. A., Naseer, M. M., Shafie, S. E. & Nada, M. A. Role of interleukin 6 and alpha-globulins in differentiating Alzheimer and vascular dementias. Neurodegener. Dis. 9, 81\u201386 (2012).","journal-title":"Neurodegener. Dis."},{"key":"884_CR100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0404.2004.00286.x","volume":"110","author":"K Wada-Isoe","year":"2004","unstructured":"Wada-Isoe, K., Wakutani, Y., Urakami, K. & Nakashima, K. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients. Acta Neurol. Scand. 110, 124\u2013127 (2004).","journal-title":"Acta Neurol. Scand."},{"key":"884_CR101","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1447-0594.2010.00686.x","volume":"11","author":"K Nagai","year":"2011","unstructured":"Nagai, K., Kozaki, K., Sonohara, K., Akishita, M. & Toba, K. Relationship between interleukin-6 and cerebral deep white matter and periventricular hyperintensity in elderly women. Geriatr. Gerontol. Int. 11, 328\u2013332 (2011).","journal-title":"Geriatr. Gerontol. Int."},{"key":"884_CR102","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1468-1331.2010.02990.x","volume":"17","author":"T Hoshi","year":"2010","unstructured":"Hoshi, T. et al. Serum inflammatory proteins and frontal lobe dysfunction in patients with cardiovascular risk factors. Eur. J. Neurol. 17, 1134\u20131140 (2010).","journal-title":"Eur. J. Neurol."},{"key":"884_CR103","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/STROKEAHA.113.004059","volume":"45","author":"BS Aribisala","year":"2014","unstructured":"Aribisala, B. S. et al. Circulating inflammatory markers are associated with magnetic resonance imaging-visible perivascular spaces but not directly with white matter hyperintensities. Stroke 45, 605\u2013607 (2014).","journal-title":"Stroke"},{"key":"884_CR104","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1006\/nbdi.2002.0556","volume":"11","author":"A De Luigi","year":"2002","unstructured":"De Luigi, A. et al. Peripheral inflammatory response in Alzheimer\u2019s disease and multiinfarct dementia. Neurobiol. Dis. 11, 308\u2013314 (2002).","journal-title":"Neurobiol. Dis."},{"key":"884_CR105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1020568013953","volume":"19","author":"E Tarkowski","year":"1999","unstructured":"Tarkowski, E., Blennow, K., Wallin, A. & Tarkowski, A. Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J. Clin. Immunol. 19, 223\u2013230 (1999).","journal-title":"J. Clin. Immunol."},{"key":"884_CR106","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston, N. R. & Ashworth, J. J. Role of C-reactive protein at sites of inflammation and infection. Front. Immunol. 9, 754 (2018).","journal-title":"Front. Immunol."},{"key":"884_CR107","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3988\/jcn.2018.14.1.29","volume":"14","author":"J Shang","year":"2018","unstructured":"Shang, J. et al. Different associations of plasma biomarkers in Alzheimer\u2019s disease, mild cognitive impairment, vascular dementia, and ischemic stroke. J. Clin. Neurol. 14, 29\u201334 (2018).","journal-title":"J. Clin. Neurol."},{"key":"884_CR108","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ajp.2017.04.015","volume":"29","author":"VY Vishnu","year":"2017","unstructured":"Vishnu, V. Y. et al. Role of inflammatory and hemostatic biomarkers in Alzheimer\u2019s and vascular dementia \u2014 a pilot study from a tertiary center in Northern India. Asian J. Psychiatry 29, 59\u201362 (2017).","journal-title":"Asian J. Psychiatry"},{"key":"884_CR109","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11596-013-1137-4","volume":"33","author":"XJ Ke","year":"2013","unstructured":"Ke, X. J. & Zhang, J. J. Changes in HIF-1alpha, VEGF, NGF and BDNF levels in cerebrospinal fluid and their relationship with cognitive impairment in patients with cerebral infarction. J. Huazhong Univ. Sci. Technol. Med. Sci. 33, 433\u2013437 (2013).","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"884_CR110","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1212\/WNL.0b013e318248e50f","volume":"78","author":"CL Satizabal","year":"2012","unstructured":"Satizabal, C. L., Zhu, Y. C., Mazoyer, B., Dufouil, C. & Tzourio, C. Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study. Neurology 78, 720\u2013727 (2012).","journal-title":"Neurology"},{"key":"884_CR111","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/CIRCULATIONAHA.104.506337","volume":"112","author":"EJ van Dijk","year":"2005","unstructured":"van Dijk, E. J. et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 112, 900\u2013905 (2005).","journal-title":"Circulation"},{"key":"884_CR112","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ane.12440","volume":"133","author":"S Mitaki","year":"2016","unstructured":"Mitaki, S., Nagai, A., Oguro, H. & Yamaguchi, S. C-reactive protein levels are associated with cerebral small vessel-related lesions. Acta Neurol. Scand. 133, 68\u201374 (2016).","journal-title":"Acta Neurol. Scand."},{"key":"884_CR113","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2007.06.053","volume":"264","author":"M Wada","year":"2008","unstructured":"Wada, M. et al. Cerebral small vessel disease and C-reactive protein: results of a cross-sectional study in community-based Japanese elderly. J. Neurol. Sci. 264, 43\u201349 (2008).","journal-title":"J. Neurol. Sci."},{"key":"884_CR114","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000352059","volume":"36","author":"J Miralbell","year":"2013","unstructured":"Miralbell, J. et al. Cognitive patterns in relation to biomarkers of cerebrovascular disease and vascular risk factors. Cerebrovasc. Dis. 36, 98\u2013105 (2013).","journal-title":"Cerebrovasc. Dis."},{"key":"884_CR115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0168-0102(01)00195-X","volume":"39","author":"M Masumura","year":"2001","unstructured":"Masumura, M., Hata, R., Nagai, Y. & Sawada, T. Oligodendroglial cell death with DNA fragmentation in the white matter under chronic cerebral hypoperfusion: comparison between normotensive and spontaneously hypertensive rats. Neurosci. Res. 39, 401\u2013412 (2001).","journal-title":"Neurosci. Res."},{"key":"884_CR116","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0047-6374(01)00313-X","volume":"122","author":"A De Luigi","year":"2001","unstructured":"De Luigi, A. et al. Inflammatory markers in Alzheimer\u2019s disease and multi-infarct dementia. Mech. Ageing Dev. 122, 1985\u20131995 (2001).","journal-title":"Mech. Ageing Dev."},{"key":"884_CR117","doi-asserted-by":"crossref","first-page":"263310552211092","DOI":"10.1177\/26331055221109254","volume":"17","author":"M Ali","year":"2022","unstructured":"Ali, M. & Bracko, O. VEGF paradoxically reduces cerebral blood flow in Alzheimer\u2019s disease mice. Neurosci. Insights 17, 26331055221109254 (2022).","journal-title":"Neurosci. Insights"},{"key":"884_CR118","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0197-4580(01)00285-8","volume":"23","author":"E Tarkowski","year":"2002","unstructured":"Tarkowski, E. et al. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer\u2019s disease and vascular dementia. Neurobiol. Aging 23, 237\u2013243 (2002).","journal-title":"Neurobiol. Aging"},{"key":"884_CR119","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13195-018-0385-8","volume":"10","author":"A Chakraborty","year":"2018","unstructured":"Chakraborty, A. et al. Vascular endothelial growth factor remains unchanged in cerebrospinal fluid of patients with Alzheimer\u2019s disease and vascular dementia. Alzheimers Res. Ther. 10, 58 (2018).","journal-title":"Alzheimers Res. Ther."},{"key":"884_CR120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/B978-0-12-386503-8.00006-5","volume":"114","author":"A Rapisarda","year":"2012","unstructured":"Rapisarda, A. & Melillo, G. Role of the VEGF\/VEGFR axis in cancer biology and therapy. Adv. Cancer Res. 114, 237\u2013267 (2012).","journal-title":"Adv. Cancer Res."},{"key":"884_CR121","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13195-022-01063-y","volume":"14","author":"K Trares","year":"2022","unstructured":"Trares, K. et al. Association of the inflammation-related proteome with dementia development at older age: results from a large, prospective, population-based cohort study. Alzheimers Res. Ther. 14, 128 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"884_CR122","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.2174\/138161206777698738","volume":"12","author":"P Lazarovici","year":"2006","unstructured":"Lazarovici, P., Marcinkiewicz, C. & Lelkes, P. I. Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF) \u2014 implications in drug development. Curr. Pharm. Des. 12, 2609\u20132622 (2006).","journal-title":"Curr. Pharm. Des."},{"key":"884_CR123","doi-asserted-by":"crossref","first-page":"828","DOI":"10.14336\/AD.2020.0222","volume":"11","author":"M Kandasamy","year":"2020","unstructured":"Kandasamy, M. et al. TGF-\u03b2 signaling: a therapeutic target to reinstate regenerative plasticity in vascular dementia? Aging Dis. 11, 828\u2013850 (2020).","journal-title":"Aging Dis."},{"key":"884_CR124","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1440-1789.2006.00701.x","volume":"26","author":"L Malaguarnera","year":"2006","unstructured":"Malaguarnera, L., Motta, M., Di Rosa, M., Anzaldi, M. & Malaguarnera, M. Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer\u2019s disease and vascular dementia. Neuropathology 26, 307\u2013312 (2006).","journal-title":"Neuropathology"},{"key":"884_CR125","doi-asserted-by":"crossref","first-page":"931473","DOI":"10.3389\/fimmu.2022.931473","volume":"13","author":"H Dong","year":"2022","unstructured":"Dong, H., Zhang, Y., Huang, Y. & Deng, H. Pathophysiology of RAGE in inflammatory diseases. Front. Immunol. 13, 931473 (2022).","journal-title":"Front. Immunol."},{"key":"884_CR126","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s12017-017-8471-9","volume":"19","author":"SC Tang","year":"2017","unstructured":"Tang, S. C. et al. Elevated plasma level of soluble form of RAGE in ischemic stroke patients with dementia. Neuromol. Med. 19, 579\u2013583 (2017).","journal-title":"Neuromol. Med."},{"key":"884_CR127","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00415-012-6465-y","volume":"259","author":"L Qian","year":"2012","unstructured":"Qian, L. et al. Early biomarkers for post-stroke cognitive impairment. J. Neurol. 259, 2111\u20132118 (2012).","journal-title":"J. Neurol."},{"key":"884_CR128","doi-asserted-by":"crossref","first-page":"105083","DOI":"10.1016\/j.phrs.2020.105083","volume":"160","author":"OY Kim","year":"2020","unstructured":"Kim, O. Y. & Song, J. The importance of BDNF and RAGE in diabetes-induced dementia. Pharmacol. Res. 160, 105083 (2020).","journal-title":"Pharmacol. Res."},{"key":"884_CR129","doi-asserted-by":"crossref","first-page":"889101","DOI":"10.3389\/fnagi.2022.889101","volume":"14","author":"LK Huang","year":"2022","unstructured":"Huang, L. K. et al. Plasma phosphorylated-tau181 is a predictor of post-stroke cognitive impairment: a longitudinal study. Front. Aging Neurosci. 14, 889101 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"884_CR130","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/glia.24163","volume":"70","author":"D Pinto-Benito","year":"2022","unstructured":"Pinto-Benito, D., Paradela-Leal, C., Ganchala, D., de Castro-Molina, P. & Arevalo, M. A. IGF-1 regulates astrocytic phagocytosis and inflammation through the p110\u03b1 isoform of PI3K in a sex-specific manner. Glia 70, 1153\u20131169 (2022).","journal-title":"Glia"},{"key":"884_CR131","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/jcbfm.2014.156","volume":"34","author":"P Toth","year":"2014","unstructured":"Toth, P. et al. IGF-1 deficiency impairs cerebral myogenic autoregulation in hypertensive mice. J. Cereb. Blood Flow Metab. 34, 1887\u20131897 (2014).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"884_CR132","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.psyneuen.2017.09.018","volume":"86","author":"P Quinlan","year":"2017","unstructured":"Quinlan, P., Horvath, A., Nordlund, A., Wallin, A. & Svensson, J. Low serum insulin-like growth factor-I (IGF-I) level is associated with increased risk of vascular dementia. Psychoneuroendocrinology 86, 169\u2013175 (2017).","journal-title":"Psychoneuroendocrinology"},{"key":"884_CR133","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2006.09.005","volume":"195","author":"Y Ban","year":"2007","unstructured":"Ban, Y. et al. Impact of increased plasma serotonin levels and carotid atherosclerosis on vascular dementia. Atherosclerosis 195, 153\u2013159 (2007).","journal-title":"Atherosclerosis"},{"key":"884_CR134","doi-asserted-by":"crossref","first-page":"105790","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105790","volume":"30","author":"J Kang","year":"2021","unstructured":"Kang, J. et al. Positive association between serum insulin-like growth factor-1 and cognition in patients with cerebral small vessel disease. J. Stroke Cerebrovasc. Dis. 30, 105790 (2021).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"884_CR135","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pneurobio.2016.08.001","volume":"144","author":"K Suk","year":"2016","unstructured":"Suk, K. Lipocalin-2 as a therapeutic target for brain injury: an astrocentric perspective. Prog. Neurobiol. 144, 158\u2013172 (2016).","journal-title":"Prog. Neurobiol."},{"key":"884_CR136","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14373-2","volume":"11","author":"F Llorens","year":"2020","unstructured":"Llorens, F. et al. Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia. Nat. Commun. 11, 619 (2020).","journal-title":"Nat. Commun."},{"key":"884_CR137","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jneuroim.2008.09.012","volume":"205","author":"JO Ojala","year":"2008","unstructured":"Ojala, J. O., Sutinen, E. M., Salminen, A. & Pirttil\u00e4, T. Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells. J. Neuroimmunol. 205, 86\u201393 (2008).","journal-title":"J. Neuroimmunol."},{"key":"884_CR138","volume":"15","author":"M Altendahl","year":"2020","unstructured":"Altendahl, M. et al. An IL-18-centered inflammatory network as a biomarker for cerebral white matter injury. PLoS ONE 15, e0227835 (2020).","journal-title":"PLoS ONE"},{"key":"884_CR139","doi-asserted-by":"crossref","first-page":"803169","DOI":"10.3389\/fcvm.2021.803169","volume":"8","author":"M Mossanen Parsi","year":"2021","unstructured":"Mossanen Parsi, M., Duval, C. & Ari\u00ebns, R. A. S. Vascular dementia and crosstalk between the complement and coagulation systems. Front. Cardiovasc. Med. 8, 803169 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"884_CR140","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000510420","volume":"49","author":"JM Pyun","year":"2020","unstructured":"Pyun, J. M., Ryoo, N., Park, Y. H. & Kim, S. Fibrinogen levels and cognitive profile differences in patients with mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 49, 489\u2013496 (2020).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"884_CR141","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/ATVBAHA.109.197368","volume":"30","author":"J Gallacher","year":"2010","unstructured":"Gallacher, J. et al. Is sticky blood bad for the brain?: hemostatic and inflammatory systems and dementia in the Caerphilly Prospective Study. Arterioscler. Thromb. Vasc. Biol. 30, 599\u2013604 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"884_CR142","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/j.1538-7836.2009.03603.x","volume":"7","author":"L Carcaillon","year":"2009","unstructured":"Carcaillon, L. et al. Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study. J. Thromb. Haemost. 7, 1972\u20131978 (2009).","journal-title":"J. Thromb. Haemost."},{"key":"884_CR143","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pjnns.2017.11.005","volume":"52","author":"J Staszewski","year":"2018","unstructured":"Staszewski, J., Piusinska-Macoch, R., Brodacki, B., Skrobowska, E. & Stepien, A. Association between hemostatic markers, serum lipid fractions and progression of cerebral small vessel disease: a 2-year follow-up study. Neurol. Neurochir. Pol. 52, 54\u201363 (2018).","journal-title":"Neurol. Neurochir. Pol."},{"key":"884_CR144","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.08.007","volume":"25","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. Endothelial function, inflammation, thrombosis, and basal ganglia perivascular spaces in patients with stroke. J. Stroke Cerebrovasc. Dis. 25, 2925\u20132931 (2016).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"884_CR145","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1161\/01.STR.0000189721.31432.26","volume":"36","author":"M van Oijen","year":"2005","unstructured":"van Oijen, M., Witteman, J. C., Hofman, A., Koudstaal, P. J. & Breteler, M. M. Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke 36, 2637\u20132641 (2005).","journal-title":"Stroke"},{"key":"884_CR146","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-0038-1650246","volume":"75","author":"D Mari","year":"1996","unstructured":"Mari, D. et al. Hemostasis abnormalities in patients with vascular dementia and Alzheimer\u2019s disease. Thromb. Haemost. 75, 216\u2013218 (1996).","journal-title":"Thromb. Haemost."},{"key":"884_CR147","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archneur.56.9.1104","volume":"56","author":"H Tomimoto","year":"1999","unstructured":"Tomimoto, H. et al. Coagulation activation in patients with Binswanger disease. Arch. Neurol. 56, 1104\u20131108 (1999).","journal-title":"Arch. Neurol."},{"key":"884_CR148","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/archneur.58.10.1620","volume":"58","author":"H Tomimoto","year":"2001","unstructured":"Tomimoto, H. et al. The coagulation-fibrinolysis system in patients with leukoaraiosis and Binswanger disease. Arch. Neurol. 58, 1620\u20131625 (2001).","journal-title":"Arch. Neurol."},{"key":"884_CR149","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ajh.2012.85","volume":"25","author":"M Nagai","year":"2012","unstructured":"Nagai, M., Hoshide, S. & Kario, K. Association of prothrombotic status with markers of cerebral small vessel disease in elderly hypertensive patients. Am. J. Hypertens. 25, 1088\u20131094 (2012).","journal-title":"Am. J. Hypertens."},{"key":"884_CR150","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1161\/01.STR.27.12.2304","volume":"27","author":"ND Tran","year":"1996","unstructured":"Tran, N. D., Wong, V. L., Schreiber, S. S., Bready, J. V. & Fisher, M. Regulation of brain capillary endothelial thrombomodulin mRNA expression. Stroke 27, 2304\u20132310 (1996).","journal-title":"Stroke"},{"key":"884_CR151","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1212\/WNL.0b013e3182407968","volume":"78","author":"MO Giwa","year":"2012","unstructured":"Giwa, M. O. et al. Neuropathologic evidence of endothelial changes in cerebral small vessel disease. Neurology 78, 167\u2013174 (2012).","journal-title":"Neurology"},{"key":"884_CR152","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","volume":"28","author":"M Cesari","year":"2010","unstructured":"Cesari, M., Pahor, M. & Incalzi, R. A. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc. Ther. 28, e72\u2013e91 (2010).","journal-title":"Cardiovasc. Ther."},{"key":"884_CR153","first-page":"2","volume":"6","author":"PJ Gaffney","year":"1977","unstructured":"Gaffney, P. J. Fibrin(-ogen) interactions with plasmin. Haemostasis 6, 2\u201325 (1977).","journal-title":"Haemostasis"},{"key":"884_CR154","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5551\/jat.E608","volume":"16","author":"Y Ban","year":"2009","unstructured":"Ban, Y. et al. Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia. J. Atheroscler. Thromb. 16, 179\u2013187 (2009).","journal-title":"J. Atheroscler. Thromb."},{"key":"884_CR155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","volume":"987","author":"N Norgren","year":"2003","unstructured":"Norgren, N., Rosengren, L. & Stigbrand, T. Elevated neurofilament levels in neurological diseases. Brain Res. 987, 25\u201331 (2003).","journal-title":"Brain Res."},{"key":"884_CR156","first-page":"6612871","volume":"2020","author":"W Ma","year":"2020","unstructured":"Ma, W. et al. Elevated levels of serum neurofilament light chain associated with cognitive impairment in vascular dementia. Dis. Markers 2020, 6612871 (2020).","journal-title":"Dis. Markers"},{"key":"884_CR157","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5853\/jos.2019.02845","volume":"22","author":"N Peters","year":"2020","unstructured":"Peters, N. et al. Serum neurofilament light chain is associated with incident lacunes in progressive cerebral small vessel disease. J. Stroke 22, 369\u2013376 (2020).","journal-title":"J. Stroke"},{"key":"884_CR158","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.18632\/aging.101925","volume":"11","author":"F Marchegiani","year":"2019","unstructured":"Marchegiani, F. et al. Diagnostic performance of new and classic CSF biomarkers in age-related dementias. Aging 11, 2420\u20132429 (2019).","journal-title":"Aging"},{"key":"884_CR159","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/jnr.1242","volume":"66","author":"M Sj\u00f6gren","year":"2001","unstructured":"Sj\u00f6gren, M. et al. Neurofilament protein in cerebrospinal fluid: a marker of white matter changes. J. Neurosci. Res. 66, 510\u2013516 (2001).","journal-title":"J. Neurosci. Res."},{"key":"884_CR160","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1468-1331.2009.02808.x","volume":"17","author":"M Jonsson","year":"2010","unstructured":"Jonsson, M. et al. Cerebrospinal fluid biomarkers of white matter lesions \u2014 cross-sectional results from the LADIS study. Eur. J. Neurol. 17, 377\u2013382 (2010).","journal-title":"Eur. J. Neurol."},{"key":"884_CR161","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3390\/biomedicines10081869","volume":"10","author":"A Huss","year":"2022","unstructured":"Huss, A. et al. Association of serum GFAP with functional and neurocognitive outcome in sporadic small vessel disease. Biomedicines 10, 1869 (2022).","journal-title":"Biomedicines"},{"key":"884_CR162","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5853\/jos.2017.02565","volume":"20","author":"M Duering","year":"2018","unstructured":"Duering, M. et al. Serum neurofilament light chain levels are related to small vessel disease burden. J. Stroke 20, 228\u2013238 (2018).","journal-title":"J. Stroke"},{"key":"884_CR163","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/jnnp-2020-325681","volume":"92","author":"M Egle","year":"2021","unstructured":"Egle, M. et al. Neurofilament light chain predicts future dementia risk in cerebral small vessel disease. J. Neurol. Neurosurg. Psychiatry 92, 582\u2013589 (2021).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"884_CR164","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin, C. et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat. Neurosci. 24, 312\u2013325 (2021).","journal-title":"Nat. Neurosci."},{"key":"884_CR165","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0889-1591(92)90049-T","volume":"6","author":"P Mecocci","year":"1992","unstructured":"Mecocci, P. et al. Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementias. Brain Behav. Immun. 6, 286\u2013292 (1992).","journal-title":"Brain Behav. Immun."},{"key":"884_CR166","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00415-022-11358-7","volume":"270","author":"T Gattringer","year":"2023","unstructured":"Gattringer, T. et al. Serum glial fibrillary acidic protein is sensitive to acute but not chronic tissue damage in cerebral small vessel disease. J. Neurol. 270, 320\u2013327 (2023).","journal-title":"J. Neurol."},{"key":"884_CR167","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0009-9120(94)00073-5","volume":"28","author":"LJ Fortin","year":"1995","unstructured":"Fortin, L. J. & Genest, J. Jr. Measurement of homocyst(e)ine in the prediction of arteriosclerosis. Clin. Biochem. 28, 155\u2013162 (1995).","journal-title":"Clin. Biochem."},{"key":"884_CR168","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3390\/ijms22042051","volume":"22","author":"R Moretti","year":"2021","unstructured":"Moretti, R., Giuffr\u00e9, M., Caruso, P., Gazzin, S. & Tiribelli, C. Homocysteine in neurology: a possible contributing factor to small vessel disease. Int. J. Mol. Sci. 22, 2051 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"884_CR169","first-page":"R1704","volume":"274","author":"F Zhang","year":"1998","unstructured":"Zhang, F., Slungaard, A., Vercellotti, G. M. & Iadecola, C. Superoxide-dependent cerebrovascular effects of homocysteine. Am. J. Physiol. 274, R1704\u2013R1711 (1998).","journal-title":"Am. J. Physiol."},{"key":"884_CR170","doi-asserted-by":"crossref","first-page":"175909141774229","DOI":"10.1177\/1759091417742296","volume":"9","author":"EM Weekman","year":"2017","unstructured":"Weekman, E. M., Woolums, A. E., Sudduth, T. L. & Wilcock, D. M. Hyperhomocysteinemia-induced gene expression changes in the cell types of the brain. ASN Neuro 9, 1759091417742296 (2017).","journal-title":"ASN Neuro"},{"key":"884_CR171","first-page":"1032","volume":"42","author":"M Malaguarnera","year":"2004","unstructured":"Malaguarnera, M. et al. Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease. Clin. Chem. Lab. Med. 42, 1032\u20131035 (2004).","journal-title":"Clin. Chem. Lab. Med."},{"key":"884_CR172","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000017092","volume":"10","author":"M Lehmann","year":"1999","unstructured":"Lehmann, M., Gottfries, C. G. & Regland, B. Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dement. Geriatr. Cogn. Disord. 10, 12\u201320 (1999).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"884_CR173","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000072812","volume":"16","author":"K Nagga","year":"2003","unstructured":"Nagga, K. et al. Cobalamin, folate, methylmalonic acid, homocysteine, and gastritis markers in dementia. Dement. Geriatr. Cogn. Disord. 16, 269\u2013275 (2003).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"884_CR174","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2007.07.011","volume":"424","author":"GK Davis","year":"2007","unstructured":"Davis, G. K. et al. Potential biomarkers for dementia in Trinidad and Tobago. Neurosci. Lett. 424, 27\u201330 (2007).","journal-title":"Neurosci. Lett."},{"key":"884_CR175","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neulet.2009.09.035","volume":"465","author":"G Davis","year":"2009","unstructured":"Davis, G., Baboolal, N., Nayak, S. & McRae, A. Sialic acid, homocysteine and CRP: potential markers for dementia. Neurosci. Lett. 465, 282\u2013284 (2009).","journal-title":"Neurosci. Lett."},{"key":"884_CR176","first-page":"1445","volume":"30","author":"L Zhang","year":"2017","unstructured":"Zhang, L., Liu, N., Zhang, J., Zhang, H. & Zhang, Y. Clinical research of homocysteine, high-sensitive C-reactive protein and D-Dimer in patients with vascular dementia. Pak. J. Pharm. Sci. 30, 1445\u20131447 (2017).","journal-title":"Pak. J. Pharm. Sci."},{"key":"884_CR177","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1212\/WNL.0000000000000168","volume":"82","author":"RP Kloppenborg","year":"2014","unstructured":"Kloppenborg, R. P. et al. Homocysteine and progression of generalized small-vessel disease: the SMART-MR study. Neurology 82, 777\u2013783 (2014).","journal-title":"Neurology"},{"key":"884_CR178","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/archneur.65.5.642","volume":"65","author":"S Seshadri","year":"2008","unstructured":"Seshadri, S. et al. Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch. Neurol. 65, 642\u2013649 (2008).","journal-title":"Arch. Neurol."},{"key":"884_CR179","doi-asserted-by":"crossref","first-page":"105302","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105302","volume":"29","author":"JS Yoo","year":"2020","unstructured":"Yoo, J. S. et al. Homocysteinemia is associated with the presence of microbleeds in cognitively impaired patients. J. Stroke Cerebrovasc. Dis. 29, 105302 (2020).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"884_CR180","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.clineuro.2011.07.004","volume":"113","author":"AM Pavlovic","year":"2011","unstructured":"Pavlovic, A. M. et al. Increased total homocysteine level is associated with clinical status and severity of white matter changes in symptomatic patients with subcortical small vessel disease. Clin. Neurol. Neurosurg. 113, 711\u2013715 (2011).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"884_CR181","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","volume":"39","author":"I Bj\u00f6rkhem","year":"1998","unstructured":"Bj\u00f6rkhem, I. et al. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39, 1594\u20131600 (1998).","journal-title":"J. Lipid Res."},{"key":"884_CR182","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-2275(20)32052-6","volume":"41","author":"D Lutjohann","year":"2000","unstructured":"Lutjohann, D. et al. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J. Lipid Res. 41, 195\u2013198 (2000).","journal-title":"J. Lipid Res."},{"key":"884_CR183","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-11-121","volume":"11","author":"G Zuliani","year":"2011","unstructured":"Zuliani, G. et al. Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer\u2019s disease or vascular dementia: a case-control study. BMC Neurol. 11, 121 (2011).","journal-title":"BMC Neurol."},{"key":"884_CR184","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference, B. A. et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur. Heart J. 38, 2459\u20132472 (2017).","journal-title":"Eur. Heart J."},{"key":"884_CR185","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1212\/WNL.0000000000000980","volume":"83","author":"S Schilling","year":"2014","unstructured":"Schilling, S. et al. Plasma lipids and cerebral small vessel disease. Neurology 83, 1844\u20131852 (2014).","journal-title":"Neurology"},{"key":"884_CR186","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3233\/JAD-191077","volume":"73","author":"E Axelsson","year":"2020","unstructured":"Axelsson, E., Wallin, A. & Svensson, J. Patients with the subcortical small vessel type of dementia have disturbed cardiometabolic risk profile. J. Alzheimers Dis. 73, 1373\u20131383 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"884_CR187","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/acn3.50973","volume":"7","author":"ER McGrath","year":"2020","unstructured":"McGrath, E. R. et al. Circulating ceramide ratios and risk of vascular brain aging and dementia. Ann. Clin. Transl. Neurol. 7, 160\u2013168 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"884_CR188","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.csbj.2020.06.001","volume":"18","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Plasma lipidomic biomarker analysis reveals distinct lipid changes in vascular dementia. Comput. Struct. Biotechnol. J. 18, 1613\u20131624 (2020).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"884_CR189","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/jcp.29987","volume":"236","author":"Q Guo","year":"2021","unstructured":"Guo, Q. et al. miR-130b-3p regulates M1 macrophage polarization via targeting IRF1. J. Cell Physiol. 236, 2008\u20132022 (2021).","journal-title":"J. Cell Physiol."},{"key":"884_CR190","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1007\/s00018-014-1628-x","volume":"71","author":"K Varendi","year":"2014","unstructured":"Varendi, K., Kumar, A., H\u00e4rma, M. A. & Andressoo, J. O. miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF. Cell Mol. Life Sci. 71, 4443\u20134456 (2014).","journal-title":"Cell Mol. Life Sci."},{"key":"884_CR191","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fncel.2016.00051","volume":"10","author":"M Ragusa","year":"2016","unstructured":"Ragusa, M. et al. miRNAs plasma profiles in vascular dementia: biomolecular data and biomedical implications. Front. Cell Neurosci. 10, 51 (2016).","journal-title":"Front. Cell Neurosci."},{"key":"884_CR192","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.7150\/thno.53418","volume":"11","author":"C Liang","year":"2021","unstructured":"Liang, C. et al. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer\u2019s disease. Theranostics 11, 4103\u20134121 (2021).","journal-title":"Theranostics"},{"key":"884_CR193","first-page":"625659","volume":"2015","author":"H Dong","year":"2015","unstructured":"Dong, H. et al. Serum microRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer\u2019s disease. Dis. Markers 2015, 625659 (2015).","journal-title":"Dis. Markers"},{"key":"884_CR194","first-page":"1145","volume":"21","author":"YY Bai","year":"2020","unstructured":"Bai, Y. Y. & Niu, J. Z. miR-222 regulates brain injury and inflammation following intracerebral hemorrhage by targeting ITGB8. Mol. Med. Rep. 21, 1145\u20131153 (2020).","journal-title":"Mol. Med. Rep."},{"key":"884_CR195","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/glia.22556","volume":"61","author":"YB Ouyang","year":"2013","unstructured":"Ouyang, Y. B. et al. Astrocyte-enriched miR-29a targets PUMA and reduces neuronal vulnerability to forebrain ischemia. Glia 61, 1784\u20131794 (2013).","journal-title":"Glia"},{"key":"884_CR196","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10571-019-00751-y","volume":"40","author":"C Barbagallo","year":"2020","unstructured":"Barbagallo, C. et al. Specific signatures of serum miRNAs as potential biomarkers to discriminate clinically similar neurodegenerative and vascular-related diseases. Cell Mol. Neurobiol. 40, 531\u2013546 (2020).","journal-title":"Cell Mol. Neurobiol."},{"key":"884_CR197","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s42003-019-0324-7","volume":"2","author":"D Shigemizu","year":"2019","unstructured":"Shigemizu, D. et al. Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data. Commun. Biol. 2, 77 (2019).","journal-title":"Commun. Biol."},{"key":"884_CR198","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/YCO.0000000000000842","volume":"36","author":"HS Joo","year":"2023","unstructured":"Joo, H. S., Jeon, H. Y., Hong, E. B., Kim, H. Y. & Lee, J. M. Exosomes for the diagnosis and treatment of dementia. Curr. Opin. Psychiatry 36, 119\u2013125 (2023).","journal-title":"Curr. Opin. Psychiatry"},{"key":"884_CR199","doi-asserted-by":"crossref","first-page":"881175","DOI":"10.3389\/fncel.2022.881175","volume":"16","author":"X Han","year":"2022","unstructured":"Han, X. et al. Circulating exo-miR-154-5p regulates vascular dementia through endothelial progenitor cell-mediated angiogenesis. Front. Cell Neurosci. 16, 881175 (2022).","journal-title":"Front. Cell Neurosci."},{"key":"884_CR200","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.21037\/atm-21-6086","volume":"9","author":"W Zhao","year":"2021","unstructured":"Zhao, W. et al. Exosomal miRNA-223-3p as potential biomarkers in patients with cerebral small vessel disease cognitive impairment. Ann. Transl. Med. 9, 1781 (2021).","journal-title":"Ann. Transl. Med."},{"key":"884_CR201","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1474-4422(09)70127-9","volume":"8","author":"H Chabriat","year":"2009","unstructured":"Chabriat, H., Joutel, A., Dichgans, M., Tournier-Lasserve, E. & Bousser, M. G. Cadasil. Lancet Neurol. 8, 643\u2013653 (2009).","journal-title":"Lancet Neurol."},{"key":"884_CR202","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jamaneurol.2022.3832","volume":"79","author":"BPH Cho","year":"2022","unstructured":"Cho, B. P. H. et al. Association of vascular risk factors and genetic factors with penetrance of variants causing monogenic stroke. JAMA Neurol. 79, 1303\u20131311 (2022).","journal-title":"JAMA Neurol."},{"key":"884_CR203","volume":"17","author":"CH Chen","year":"2020","unstructured":"Chen, C. H., Cheng, Y. W., Chen, Y. F., Tang, S. C. & Jeng, J. S. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL. J. Neuroinflammation 17, 124 (2020).","journal-title":"J. Neuroinflammation"},{"key":"884_CR204","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/acn3.678","volume":"6","author":"G Gravesteijn","year":"2019","unstructured":"Gravesteijn, G. et al. Serum neurofilament light correlates with CADASIL disease severity and survival. Ann. Clin. Transl. Neurol. 6, 46\u201356 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"884_CR205","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.10.027","volume":"26","author":"F Pescini","year":"2017","unstructured":"Pescini, F. et al. Circulating biomarkers in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy patients. J. Stroke Cerebrovasc. Dis. 26, 823\u2013833 (2017).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"884_CR206","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1159\/000166840","volume":"26","author":"A Rufa","year":"2008","unstructured":"Rufa, A. et al. Plasma levels of asymmetric dimethylarginine in cerebral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy. Cerebrovasc. Dis. 26, 636\u2013640 (2008).","journal-title":"Cerebrovasc. Dis."},{"key":"884_CR207","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brainres.2016.05.008","volume":"1644","author":"V Primo","year":"2016","unstructured":"Primo, V. et al. Blood biomarkers in a mouse model of CADASIL. Brain Res. 1644, 118\u2013126 (2016).","journal-title":"Brain Res."},{"key":"884_CR208","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3988\/jcn.2023.19.1.12","volume":"19","author":"Y Yamamoto","year":"2023","unstructured":"Yamamoto, Y., Liao, Y. C., Lee, Y. C., Ihara, M. & Choi, J. C. Update on the epidemiology, pathogenesis, and biomarkers of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J. Clin. Neurol. 19, 12\u201327 (2023).","journal-title":"J. Clin. Neurol."},{"key":"884_CR209","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2990.2010.01147.x","volume":"37","author":"Y Yamamoto","year":"2011","unstructured":"Yamamoto, Y., Craggs, L., Baumann, M., Kalimo, H. & Kalaria, R. N. Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol. Appl. Neurobiol. 37, 94\u2013113 (2011).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"884_CR210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.matbio.2022.11.007","volume":"115","author":"K Branyan","year":"2023","unstructured":"Branyan, K. et al. Elevated TGF\u03b2 signaling contributes to cerebral small vessel disease in mouse models of Gould syndrome. Matrix Biol. 115, 48\u201370 (2023).","journal-title":"Matrix Biol."},{"key":"884_CR211","doi-asserted-by":"crossref","first-page":"619721","DOI":"10.3389\/fneur.2021.619721","volume":"12","author":"M Dagonnier","year":"2021","unstructured":"Dagonnier, M., Donnan, G. A., Davis, S. M., Dewey, H. M. & Howells, D. W. Acute stroke biomarkers: are we there yet? Front. Neurol. 12, 619721 (2021). A review of biomarkers associated with stroke.","journal-title":"Front. Neurol."},{"key":"884_CR212","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000252773","volume":"28","author":"M Bjerke","year":"2009","unstructured":"Bjerke, M. et al. Subcortical vascular dementia biomarker pattern in mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 28, 348\u2013356 (2009).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"884_CR213","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2147\/CIA.S166773","volume":"13","author":"J Staszewski","year":"2018","unstructured":"Staszewski, J., Piusinska-Macoch, R., Brodacki, B., Skrobowska, E. & Stepien, A. IL-6, PF-4, sCD40 L, and homocysteine are associated with the radiological progression of cerebral small-vessel disease: a 2-year follow-up study. Clin. Interv. Aging 13, 1135\u20131141 (2018).","journal-title":"Clin. Interv. Aging"},{"key":"884_CR214","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1136\/jnnp-2014-309421","volume":"86","author":"GA Rosenberg","year":"2015","unstructured":"Rosenberg, G. A. et al. Validation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials. J. Neurol. Neurosurg. Psychiatry 86, 1324\u20131330 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"884_CR215","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fnins.2020.00084","volume":"14","author":"Z Winder","year":"2020","unstructured":"Winder, Z. et al. Hierarchical clustering analyses of plasma proteins in subjects with cardiovascular risk factors identify informative subsets based on differential levels of angiogenic and inflammatory biomarkers. Front. Neurosci. 14, 84 (2020).","journal-title":"Front. Neurosci."},{"key":"884_CR216","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/ijms19041057","volume":"19","author":"DH Kong","year":"2018","unstructured":"Kong, D. H., Kim, Y. K., Kim, M. R., Jang, J. H. & Lee, S. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. Int. J. Mol. Sci. 19, 1057 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"884_CR217","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-022-04075-0","volume":"26","author":"J Singh","year":"2022","unstructured":"Singh, J., Lee, Y. & Kellum, J. A. A new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approach. Crit. Care 26, 246 (2022).","journal-title":"Crit. Care"},{"key":"884_CR218","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fmed.2020.00543","volume":"7","author":"M Steinert","year":"2020","unstructured":"Steinert, M., Ramming, I. & Bergmann, S. Impact of Von Willebrand factor on bacterial pathogenesis. Front. Med. 7, 543 (2020).","journal-title":"Front. Med."},{"key":"884_CR219","doi-asserted-by":"publisher","unstructured":"Saki, N., Javan, M., Moghimian-Boroujeni, B. & Kast, R. E. Interesting effects of interleukins and immune cells on acute respiratory distress syndrome. Clin. Exp. Med. https:\/\/doi.org\/10.1007\/s10238-023-01118-w (2023).","DOI":"10.1007\/s10238-023-01118-w"},{"key":"884_CR220","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/01.STR.0000237236.88823.47","volume":"37","author":"V Hachinski","year":"2006","unstructured":"Hachinski, V. et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37, 2220\u20132241 (2006).","journal-title":"Stroke"},{"key":"884_CR221","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1212\/01.WNL.0000115108.65264.4B","volume":"62","author":"PS Sachdev","year":"2004","unstructured":"Sachdev, P. S. et al. The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology 62, 912\u2013919 (2004).","journal-title":"Neurology"},{"key":"884_CR222","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archneur.63.2.246","volume":"63","author":"R Au","year":"2006","unstructured":"Au, R. et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch. Neurol. 63, 246\u2013250 (2006).","journal-title":"Arch. Neurol."},{"key":"884_CR223","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nrneurol.2014.181","volume":"10","author":"PS Sachdev","year":"2014","unstructured":"Sachdev, P. S. et al. Classifying neurocognitive disorders: the DSM-5 approach. Nat. Rev. Neurol. 10, 634\u2013642 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"884_CR224","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jamaneurol.2022.2262","volume":"79","author":"HS Markus","year":"2022","unstructured":"Markus, H. S. et al. Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE): a review. JAMA Neurol. 79, 1187\u20131198 (2022).","journal-title":"JAMA Neurol."},{"key":"884_CR225","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s43587-021-00043-5","volume":"1","author":"WA Banks","year":"2021","unstructured":"Banks, W. A., Reed, M. J., Logsdon, A. F., Rhea, E. M. & Erickson, M. A. Healthy aging and the blood-brain barrier. Nat. Aging 1, 243\u2013254 (2021).","journal-title":"Nat. Aging"},{"key":"884_CR226","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41582-020-0362-2","volume":"16","author":"KD Davis","year":"2020","unstructured":"Davis, K. D. et al. Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities. Nat. Rev. Neurol. 16, 381\u2013400 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"884_CR227","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s11357-022-00556-w","volume":"44","author":"C Custodero","year":"2022","unstructured":"Custodero, C. et al. Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis. Geroscience 44, 1373\u20131392 (2022).","journal-title":"Geroscience"},{"key":"884_CR228","doi-asserted-by":"crossref","first-page":"105015","DOI":"10.1016\/j.neuint.2021.105015","volume":"146","author":"S Hosoki","year":"2021","unstructured":"Hosoki, S., Tanaka, T. & Ihara, M. Diagnostic and prognostic blood biomarkers in vascular dementia: from the viewpoint of ischemic stroke. Neurochem. Int. 146, 105015 (2021). A review of biomarkers associated with VCID and stroke.","journal-title":"Neurochem. Int."},{"key":"884_CR229","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41582-022-00650-9","volume":"18","author":"M Ihara","year":"2022","unstructured":"Ihara, M. & Yamamoto, Y. Transcriptomic mapping of the human cerebrovasculature. Nat. Rev. Neurol. 18, 319\u2013320 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"884_CR230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"884_CR231","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling, R. A. et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup. Alzheimers Dement. 7, 367\u2013385 (2011).","journal-title":"Alzheimers Dement."},{"key":"884_CR232","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1161\/STROKEAHA.121.032616","volume":"52","author":"M Dichgans","year":"2021","unstructured":"Dichgans, M., Beaufort, N., Debette, S. & Anderson, C. D. Stroke genetics: turning discoveries into clinical applications. Stroke 52, 2974\u20132982 (2021).","journal-title":"Stroke"},{"key":"884_CR233","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"GC Rom\u00e1n","year":"1993","unstructured":"Rom\u00e1n, G. C. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250\u2013260 (1993).","journal-title":"Neurology"},{"key":"884_CR234","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/WAD.0000000000000034","volume":"28","author":"P Sachdev","year":"2014","unstructured":"Sachdev, P. et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis. Assoc. Disord. 28, 206\u2013218 (2014).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"884_CR235","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2017.09.007","volume":"14","author":"OA Skrobot","year":"2018","unstructured":"Skrobot, O. A. et al. Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement. 14, 280\u2013292 (2018).","journal-title":"Alzheimers Dement."},{"key":"884_CR236","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr.","year":"1993","unstructured":"Adams, H. P. Jr. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24, 35\u201341 (1993).","journal-title":"Stroke"},{"key":"884_CR237","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th edn (American Psychiatric Association, 1994)."},{"key":"884_CR238","unstructured":"World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders (World Health Organization, 1992)."},{"key":"884_CR239","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/WNL.42.3.473","volume":"42","author":"HC Chui","year":"1992","unstructured":"Chui, H. C. et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer\u2019s Disease Diagnostic and Treatment Centers. Neurology 42, 473\u2013480 (1992).","journal-title":"Neurology"},{"key":"884_CR240","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Association, 2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"884_CR241","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/CIRCRESAHA.122.319951","volume":"130","author":"NS Rost","year":"2022","unstructured":"Rost, N. S. et al. Post-stroke cognitive impairment and dementia. Circ. Res. 130, 1252\u20131271 (2022).","journal-title":"Circ. Res."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00884-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00884-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00884-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T14:16:43Z","timestamp":1701094603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00884-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":241,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["884"],"URL":"https:\/\/doi.org\/10.1038\/s41582-023-00884-1","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"29 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}